March 15, 2025 - 21:42

In a significant move, Governor Mark Gordon has vetoed a bill passed by Wyoming lawmakers that sought to declare abortion as not being a form of health care. This decision comes at a critical time as the Wyoming Supreme Court is set to hear challenges to two abortion bans enacted earlier in 2023.
The veto reflects the ongoing debate surrounding reproductive rights in the state, where opinions on abortion remain deeply divided. Proponents of the bill argued that it was necessary to clarify the state's stance on abortion, while opponents contended that it undermines women's health care.
Governor Gordon's veto is seen as a pivotal moment in Wyoming's legislative landscape, especially as legal battles over abortion access continue to unfold. As the Supreme Court prepares to review the existing bans, the implications of the governor's decision are likely to resonate throughout the state and beyond, influencing future discussions on reproductive rights and health care.
October 21, 2026 - 01:41
Ebola Case Confirmed in Abuja After Traveler Arrives From UgandaNigeria has confirmed an Ebola case in Abuja after a woman arriving from Uganda tested positive, making the country the latest in the region to report an infection as the outbreak continues to...
October 20, 2026 - 03:18
CIM Holds Annual Health and Benefits Fair for StaffThe California Institution for Men in Chino recently hosted its yearly Employee Health and Benefits Fair, giving staff a chance to learn about the resources available to them and their...
October 19, 2026 - 05:23
Health Officials Push for Flu Vaccinations as Early Cases Rise in Some StatesVirginia health officials are urging residents to get their flu shots as data from other parts of the country points to an early jump in infections this season. So far, only about 10 percent of...
October 18, 2026 - 21:18
VA Doctor Leads National Trial on GLP-1 Drugs for Alcohol Use DisorderA physician at the Philadelphia Veterans Affairs Medical Center is heading a nationwide clinical trial that will examine whether GLP-1 receptor agonists, the class of medications best known for...